Resumen

DISCOVER is a Non Interventional Study study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment.

Descripción detallada

DISCOVER is a NIS study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment. This study is a multi-country, multicenter, observational, prospective, longitudinal cohort study. The patients will be recruitted from countries in Latin America, Europe and Asia pac. It is estimated that approximately 13350 patients will be enrolled in total with each patient followed up for 3 years.

Elegibilidad

Edad mínima: 18 YearsSexo: ALL

Criterios de inclusión

Provision of subject informed consent
Female or male aged 18 years and over
Diagnosed with type 2 diabetes mellitus
Initiating a second line anti-diabetic therapy, either as add-on, or switching from one monotherapy to another.

Criterios de exclusión

Diagnosis of type 1 diabetes mellitus
Patient is pregnant
Patients initiating a dual therapy after having previously received two different lines of monotherapy before (e.g.: Metformin → SU (Sulphonylureas) → SU+Add-on)
Current treatment with chemotherapy, oral or iv steroids
Patient is on dialysis or has had a renal transplant
The patient is taking insulin as first line treatment
The patient is taking dual therapy or a fixed dose combination treatment as first line treatment.
The patient is taking herbal remedies / natural medicines as first line treatment
Participation in an interventional trial
Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient for 3 years (e.g. lifethreatening co-morbidities, tourist, non-native speaker or does not understand the local language where interpreter services are not reliably available, psychiatric disturbances, dementia, alcohol or drug abuse).
Not willing to sign the informed consent.

Ubicaciones

Research Site

Buenos Aires, Argentina

Research Site

Chacabuco, Argentina

Research Site

Ciudad Autonoma Buenos Aires, Argentina

Research Site

Corrientes, Argentina

Research Site

Córdoba, Argentina

Research Site

Paraná, Argentina

Research Site

Rosario, Argentina

Research Site

San Miguel de Tucumán, Argentina

Research Site

Santa Fe, Argentina

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings

Resumen

Descripción detallada

Elegibilidad

Criterios de inclusión

Criterios de exclusión

Ubicaciones

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Patrocinadores